Transportation Healthcare Sector

Faron Pharmaceuticals Oy

Market Cap: UK£340.3m

Operates as a clinical stage drug discovery and development company.

Allergy Therapeutics

Market Cap: UK£338.4m

A commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders.

Altimmune

Market Cap: US$455.0m

A clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases.

PYC Therapeutics

Market Cap: AU$705.7m

A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.

REGENXBIO

Market Cap: US$449.9m

A clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States.

kneat.com

Market Cap: CA$614.0m

Designs, develops, and supplies software for data and document management within regulated environments in North America, Europe, and the Asia Pacific.

Semler Scientific

Market Cap: US$447.0m

Provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States.

Clarity Pharmaceuticals

Market Cap: AU$694.1m

A clinical stage radiopharmaceutical company, engages in research and development and clinical stage radiopharmaceuticals products in Australia and the United States.

Oruka Therapeutics

Market Cap: US$443.7m

A clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications.

Orthofix Medical

Market Cap: US$442.0m

Operates as a medical technology company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally.

PureTech Health

Market Cap: UK£327.1m

Engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.

SIGA Technologies

Market Cap: US$440.1m

A commercial-stage pharmaceutical company, focuses on the health security market in the United States.

Maze Therapeutics

Market Cap: US$438.4m

A clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, related metabolic diseases, and obesity in the United States.

Sonida Senior Living

Market Cap: US$437.3m

Owns and operates senior housing communities in the United States.

Cross Country Healthcare

Market Cap: US$437.0m

Provides talent management services for healthcare clients in the United States.

Amylyx Pharmaceuticals

Market Cap: US$436.8m

A clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States.

Bioventus

Market Cap: US$435.3m

A medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally.

CytoDyn

Market Cap: US$434.6m

A clinical-stage biotechnology company, engages in the development of treatments for multiple therapeutic indications.

Senseonics Holdings

Market Cap: US$431.9m

A commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally.

MeiraGTx Holdings

Market Cap: US$430.8m

A clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases.

NeuroPace

Market Cap: US$430.0m

Operates as a medical device company in the United States.

Humacyte

Market Cap: US$429.7m

Engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas.

Zhengye Biotechnology Holding

Market Cap: US$427.5m

Engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China.

Verastem

Market Cap: US$427.0m

A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.

Tourmaline Bio

Market Cap: US$424.1m

Operates as a clinical biotechnology company that develops medicines for patients with life-altering immune and inflammatory diseases.

Surmodics

Market Cap: US$422.3m

Provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally.

Development Technologies

Market Cap: US$420.0m

Pegasus Pharmaceuticals Inc. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies.

Paragon Care

Market Cap: AU$653.8m

Distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia.

Zenas BioPharma

Market Cap: US$418.3m

A clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies.

Tectonic Therapeutic

Market Cap: US$418.3m

A biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein-coupled receptors (GPCRs).

Knight Therapeutics

Market Cap: CA$572.9m

Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.

MBX Biosciences

Market Cap: US$415.1m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders.

Vitalhub

Market Cap: CA$567.9m

Provides technology and software solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally.

Septerna

Market Cap: US$412.2m

A clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases.

Erasca

Market Cap: US$410.8m

A clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.

Precigen

Market Cap: US$410.3m

A discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.